Balic et al. demonstrated that CQ preferentially targeted CSCs via inhibition of CXCR4 and hedgehog signaling in pancreatic cancer, which acted through autophagy-independent mode of action (21). The gene discussed is CXCR4; the disease is pancreatic neoplasm.